You can reach Lizzy on Signal at lizzylaw.53. The Food and Drug Administration canceled an upcoming vaccine advisory committee meeting to discuss influenza virus strains, according to committee ...

Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San ...

Capricor Therapeutics' rating was downgraded amid FDA inspection risks, regulatory uncertainty, and potential delays in ...

The FDA's Vaccines and Related Biological Products Advisory Committee was scheduled for next month. But the agency notified committee members that the meeting had been canceled. The Food and Drug ...

The company said the FDA is considering holding an advisory committee meeting, though the agency provided no official date. Capricor CEO Linda Marbán said the company has been “actively ...

The FDA will hold its first Digital Health Advisory Committee (DHAC) meeting to discuss how the agency should review medical devices that rely on generative AI, like chatbots. The meeting will be ...

In recent years, several senior FDA officials have publicly hinted at possible advisory committee reforms, following increased attention to advisory committee meetings during the COVID-19 pandemic ...

"A planned March 13 meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee on the influenza vaccine strains for the 2025-2026 influenza season in the northern ...

The FDA's Advisory Committee calendar, updated as of Wednesday, shows no March meetings scheduled. As for the VRBPAC specifically, its "meeting materials" archive shows no content for the current ...